Accelus
PrivateLast Round
Early Funding
May 29, 2025
Total Funding Raised
$38.81M
Momentum Score
25 /100
Company Overview
Accelus is a medical technology company that provides a portfolio of MIS spinal implants and a compact precision robotics platform to accelerate the adoption of minimally invasive surgery as the standard of care in spine.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Accelus Comps
Public and private peers based on sector, stage, and business model.
Accelus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 29, 2025 | ||||
| Debt | Jan 18, 2024 | ||||
| Series D | Jul 12, 2022 | ||||
| Seed | Feb 27, 2020 | ||||
| Angel | Jun 25, 2019 |
Accelus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Symbiotic Capital | Debt |
| Concord Health Partners | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2025
Highridge Medical acquired products and assets to expand spine surgery capabilities.
- May 29, 2025
$6M raised in early funding.
Accelus Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Accelus's valuation, stock price, and market status.
